AzTrials
AzTrials

Health LiteracyTeach-Back MetNCT07777289

A TEACH-BACK APPROACH TO INCREASE BREAST CANCER KNOWLEDGE IN WOMEN WITH LOW HEALTH LITERACY: AN INTERVENTION STUDY

A study testing Routine Health Education in people with Health Literacy and Breast Cancer Awareness, run by Buca Seyfi Demirsoy State Hospital.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Objective: This study aims to evaluate the effectiveness of the "Teach Back" technique in increasing breast cancer knowledge among women with limited health literacy. Method: This research is a randomized controlled experimental study. Read more about this study

Who is it for?
Ages 18 to 80 years, women onlyHealthy volunteers can take part
Conditions the study is for
Health Literacy, Breast Cancer Awareness
What is being tested?
Routine Health Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
No sites listed yet
Study dates
Sep 2026to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • Women over 18 years of age,
  • Having a health literacy score below 25 on the Turkish Health Literacy Scale.
  • Not having a diagnosed mental, visual, or learning disability by a physician.
  • Not having previously participated in any research project on breast health/breast education.
  • Being able to communicate verbally.
  • Not having breast cancer.

Who cannot join

  • • Having a previous diagnosis of breast cancer. • Having cognitive impairments that may prevent participation in the study. • Having hearing or visual impairments that may negatively affect participation and interaction in the training process. • Lack of sufficient language proficiency to understand the training materials.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

huri Yoğurtcu, MD, PhD contact

+90-507-064-0824

huri.yogurtcu@gmail.com

About this study

Objective: This study aims to evaluate the effectiveness of the "Teach Back" technique in increasing breast cancer knowledge among women with limited health literacy.

Method: This research is a randomized controlled experimental study. The study is planned to be conducted with individuals who applied to the KETEM unit of Healthy Life Center No. 1, affiliated with the Karabağlar District Health Directorate in İzmir.

Read more

Data will be evaluated for normality; dependent samples t-test will be used for pre- and post-education comparisons, and Wilcoxon signed-rank test will be used if normality is not achieved. Baseline differences between the experimental and control groups will be analyzed with independent samples t-test or Mann-Whitney U test, and categorical variables will be analyzed with the Chi-square test. In the study, the experimental group will receive breast cancer education in groups of 5, consisting of 20-minute sessions with a 4-week interval, presented in simple language avoiding medical jargon, and the education content will be re-explained by the participants in their own words. These sessions will consist of general content such as breast cancer risk factors, symptoms, and the importance of early diagnosis.

  1. What are the risk factors and symptoms of breast cancer?
  2. The importance of early detection of breast cancer (BSE, clinical breast examination (CBE), mammography).
  3. What are the treatment options for breast cancer? (Surgical methods, systemic treatments (endocrine therapy, chemotherapy, hormonal therapy), and radiotherapy) (Kiyat \& Akyüz, 2024; Uçkaç, 2022; Altu et al., 2023; Hosseinifar, Afkhamzadeh \& Moayeri, 2024).

The control group will be educated using existing educational materials used by the Ministry of Health. The content of these trainings will consist of topics such as breast cancer risk factors, symptoms, and the importance of early diagnosis. The Teach Back technique will not be applied to the control group.

Read the detailed description

Objective: This study aims to evaluate the effectiveness of the "Teach Back" technique in increasing breast cancer knowledge among women with limited health literacy.

Method: This research is a randomized controlled experimental study. The study is planned to be conducted with individuals who applied to the KETEM unit of Healthy Life Center No. 1, affiliated with the Karabağlar District Health Directorate in İzmir.

Data will be evaluated for normality; dependent samples t-test will be used for pre- and post-education comparisons, and Wilcoxon signed-rank test will be used if normality is not achieved. Baseline differences between the experimental and control groups will be analyzed with independent samples t-test or Mann-Whitney U test, and categorical variables will be analyzed with the Chi-square test. In the study, the experimental group will receive breast cancer education in groups of 5, consisting of 20-minute sessions with a 4-week interval, presented in simple language avoiding medical jargon, and the education content will be re-explained by the participants in their own words. These sessions will consist of general content such as breast cancer risk factors, symptoms, and the importance of early diagnosis.

  1. What are the risk factors and symptoms of breast cancer?
  2. The importance of early detection of breast cancer (BSE, clinical breast examination (CBE), mammography).
  3. What are the treatment options for breast cancer? (Surgical methods, systemic treatments (endocrine therapy, chemotherapy, hormonal therapy), and radiotherapy) (Kiyat \& Akyüz, 2024; Uçkaç, 2022; Altu et al., 2023; Hosseinifar, Afkhamzadeh \& Moayeri, 2024).

The control group will be educated using existing educational materials used by the Ministry of Health. The content of these trainings will consist of topics such as breast cancer risk factors, symptoms, and the importance of early diagnosis. The Teach Back technique will not be applied to the control group.

Being tested
Routine Health Education
Keywords
Breast Cancer, Health Literacy, Teach-Back Method, Health Education
Medical subject headings
Breast Neoplasms, Health Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Routine Health EducationOther

    Also called Teach-Back Method Education, Standard Care Education

    Structured individual health education on breast cancer screening and awareness delivered using the Teach-Back method to ensure comprehension among participants with low health literacy.

Study groups in NCT07777289
Study groupRoleWhat they receive
Intervention GroupExperimentalParticipants receive structured individual breast cancer awareness and screening education delivered using the Teach-Back method.
Receives: Other: Routine Health Education
Control GroupNo interventionParticipants receive standard breast cancer awareness and screening education provided through routine health center procedures.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Breast Cancer Knowledge Level

    Assessed using the Knowledge Scale for Breast Cancer and Screening Methods (GKMKBT). Total scores range from 0 to 44, with higher scores indicating greater knowledge regarding breast cancer and screening procedures.

    Measured: Baseline (pre-intervention) and 1 month post-intervention

Secondary outcomes (1)
  1. Change in Health Literacy Level

    Assessed using the Turkey Health Literacy Scale-32 (TSOY-32). Scores range from 0 to 50, where higher scores represent higher health literacy levels.

    Measured: Baseline (pre-intervention) and 1 month post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07777289
Sponsor's protocol ID
10621-GOA
Acronym
Teach-Back Met
Status last verified
Aug 2026
First submitted
17 Aug 2026
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared to protect participant privacy and maintain confidentiality, as explicit consent for secondary data sharing was not obtained from participants under the approved study protocol.

Questions about this trial

What is this clinical trial studying?

A study testing Routine Health Education in people with Health Literacy and Breast Cancer Awareness, run by Buca Seyfi Demirsoy State Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact huri Yoğurtcu, MD, PhD (+90-507-064-0824, huri.yogurtcu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Breast Cancer Knowledge Level (time frame: Baseline (pre-intervention) and 1 month post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in